Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | %Female (2008) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
159 | Advances in Gastrointestinal Cancers | journal | 0.101 Q4 | 1 | 25 | 71 | 523 | 0 | 35 | 0.00 | 20.92 | 38.10 | |
158 | Enhancer - Biotherapy of Cancer | journal | 0.101 Q4 | 0 | 0 | 43 | 0 | 0 | 21 | 0.00 | 0.00 | 0.00 | |
157 | Tumor Research | journal | 0.101 Q4 | 3 | 3 | 14 | 97 | 0 | 14 | 0.00 | 32.33 | 10.34 | |
156 | ecancermedicalscience | journal | 0.103 Q4 | 47 | 0 | 7 | 0 | 1 | 7 | 0.14 | 0.00 | 0.00 | |
155 | Women's Oncology Review | journal | 0.103 | 4 | 0 | 106 | 0 | 1 | 102 | 0.00 | 0.00 | 0.00 | |
154 | Annals of Cancer Research and Therapy | journal | 0.105 Q4 | 7 | 11 | 23 | 173 | 1 | 23 | 0.07 | 15.73 | 16.67 | |
153 | Oncology Reviews | journal | 0.105 Q4 | 31 | 40 | 20 | 2470 | 1 | 19 | 0.05 | 61.75 | 39.58 | |
152 | Turkish Journal of Cancer | journal | 0.108 Q4 | 10 | 29 | 84 | 605 | 3 | 84 | 0.02 | 20.86 | 41.96 | |
151 | Journal of Cell and Molecular Biology | journal | 0.112 Q4 | 13 | 6 | 19 | 332 | 2 | 17 | 0.11 | 55.33 | 18.18 | |
150 | Breast Cancer Online | journal | 0.113 Q4 | 3 | 13 | 45 | 258 | 5 | 45 | 0.11 | 19.85 | 45.45 | |
149 | Nowotwory | journal | 0.114 Q4 | 11 | 77 | 178 | 1524 | 22 | 175 | 0.07 | 19.79 | 33.49 | |
148 | Onkologia Polska | journal | 0.118 Q4 | 7 | 33 | 114 | 571 | 18 | 113 | 0.23 | 17.30 | 58.20 | |
147 | Cancer Forum | journal | 0.121 Q4 | 15 | 35 | 94 | 890 | 13 | 90 | 0.11 | 25.43 | 38.60 | |
146 | Cancer journal (Sudbury, Mass.) | journal | 0.122 Q4 | 102 | 73 | 212 | 3169 | 507 | 168 | 2.60 | 43.41 | 35.50 | |
145 | Clinical and Experimental Medical Letters | journal | 0.123 Q4 | 6 | 46 | 40 | 1093 | 3 | 40 | 0.08 | 23.76 | 40.29 | |
144 | Japanese Journal of Cancer and Chemotherapy | journal | 0.123 Q4 | 25 | 559 | 1411 | 640 | 188 | 1411 | 0.14 | 1.14 | 14.40 | |
143 | Biotherapy | journal | 0.126 Q4 | 8 | 55 | 190 | 1041 | 7 | 190 | 0.04 | 18.93 | 9.90 | |
142 | Reports of Practical Oncology and Radiotherapy | journal | 0.128 Q4 | 36 | 38 | 113 | 684 | 15 | 103 | 0.14 | 18.00 | 45.45 | |
141 | Current Hematologic Malignancy Reports | journal | 0.135 Q4 | 44 | 27 | 70 | 1233 | 3 | 68 | 0.04 | 45.67 | 29.03 | |
140 | Supportive Cancer Therapy | journal | 0.153 Q4 | 15 | 0 | 66 | 0 | 20 | 55 | 0.30 | 0.00 | 0.00 | |
139 | Brain Tumor Pathology | journal | 0.166 Q4 | 45 | 15 | 48 | 454 | 19 | 46 | 0.38 | 30.27 | 4.05 | |
138 | Advances in Breast Cancer | journal | 0.169 Q4 | 4 | 29 | 83 | 414 | 5 | 30 | 0.06 | 14.28 | 51.85 | |
137 | Update on Cancer Therapeutics | journal | 0.182 Q4 | 13 | 9 | 53 | 853 | 24 | 52 | 0.45 | 94.78 | 25.00 | |
136 | Journal of B.U.ON. | journal | 0.191 Q4 | 37 | 101 | 291 | 2582 | 145 | 270 | 0.58 | 25.56 | 35.67 | |
135 | National Toxicology Program technical report series | journal | 0.221 | 22 | 7 | 20 | 0 | 15 | 20 | 0.82 | 0.00 | 0.00 | |
134 | European Journal of Cancer, Supplement | journal | 0.235 Q4 | 29 | 48 | 224 | 1524 | 169 | 208 | 1.05 | 31.75 | 30.15 | |
133 | Tumori | journal | 0.302 Q4 | 59 | 189 | 429 | 4346 | 351 | 403 | 0.82 | 22.99 | 36.81 | |
132 | Bulletin du Cancer | journal | 0.307 Q4 | 44 | 194 | 548 | 6150 | 498 | 487 | 0.92 | 31.70 | 40.65 | |
131 | Clinical and Translational Oncology | journal | 0.315 Q4 | 61 | 155 | 415 | 4810 | 290 | 360 | 0.81 | 31.03 | 44.03 | |
130 | Targeted Oncology | journal | 0.351 Q4 | 59 | 33 | 63 | 1561 | 35 | 56 | 0.56 | 47.30 | 28.04 | |
129 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.400 Q4 | 56 | 37 | 50 | 1092 | 108 | 48 | 2.84 | 29.51 | 43.82 | |
128 | In Vivo | journal | 0.415 | 72 | 135 | 474 | 4031 | 592 | 472 | 1.06 | 29.86 | 31.26 | |
127 | Cancer Genomics and Proteomics | journal | 0.450 Q3 | 50 | 26 | 112 | 952 | 96 | 111 | 1.07 | 36.62 | 32.47 | |
126 | Cancer Treatment and Research | journal | 0.475 Q3 | 65 | 68 | 186 | 5057 | 194 | 186 | 0.99 | 74.37 | 35.09 | |
125 | Infectious Agents and Cancer | journal | 0.477 Q3 | 47 | 14 | 32 | 781 | 38 | 32 | 1.19 | 55.79 | 51.69 | |
124 | Human Cell | journal | 0.482 Q3 | 44 | 14 | 51 | 385 | 64 | 51 | 1.55 | 27.50 | 10.94 | |
123 | Cancer Informatics | journal | 0.491 Q3 | 37 | 34 | 83 | 1221 | 84 | 77 | 1.04 | 35.91 | 31.40 | |
122 | Oncology | journal | 0.491 Q3 | 83 | 218 | 647 | 3980 | 489 | 416 | 0.69 | 18.26 | 34.55 | |
121 | Oncology Research and Treatment | journal | 0.491 Q3 | 55 | 152 | 295 | 2802 | 355 | 241 | 1.20 | 18.43 | 27.59 | |
120 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.503 Q3 | 68 | 80 | 247 | 2813 | 394 | 237 | 1.36 | 35.16 | 33.99 | |
119 | Journal of Experimental and Clinical Cancer Research | journal | 0.507 Q3 | 120 | 86 | 249 | 3113 | 323 | 246 | 1.26 | 36.20 | 31.85 | |
118 | Pathology and Oncology Research | journal | 0.530 Q3 | 61 | 75 | 147 | 2276 | 215 | 138 | 1.46 | 30.35 | 40.47 | |
117 | Neoplasma | journal | 0.535 Q3 | 57 | 83 | 252 | 3094 | 392 | 252 | 1.48 | 37.28 | 42.58 | |
116 | Oncology Research | journal | 0.541 Q3 | 76 | 30 | 109 | 1115 | 164 | 109 | 1.44 | 37.17 | 30.23 | |
115 | Current Problems in Cancer | journal | 0.559 Q3 | 47 | 15 | 58 | 956 | 75 | 43 | 1.66 | 63.73 | 20.00 | |
114 | Medical Oncology | journal | 0.562 Q3 | 90 | 80 | 187 | 2204 | 260 | 186 | 1.22 | 27.55 | 36.29 | |
113 | Anticancer Research | journal | 0.609 Q3 | 136 | 535 | 2059 | 16536 | 3264 | 2059 | 1.58 | 30.91 | 31.26 | |
112 | International Journal of Biological Markers | journal | 0.636 Q3 | 47 | 41 | 128 | 1348 | 190 | 120 | 1.54 | 32.88 | 37.25 | |
111 | Japanese Journal of Clinical Oncology | journal | 0.649 Q3 | 95 | 155 | 460 | 3106 | 798 | 444 | 1.59 | 20.04 | 14.16 | |
110 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.673 Q3 | 65 | 74 | 231 | 2535 | 417 | 216 | 1.70 | 34.26 | 29.62 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®